Abstract
Outcomes in Patients with Spinal Muscular Atrophy and Four or More SMN2 Copies Treated with Onasemnogene Abeparvovec: Findings from RESTORE (P7-9.007)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have